About 30 Mg Paclitaxel Injection IP
Unlock first-class cancer therapy at a reduced price with 30 Mg Paclitaxel Injection IP-ending soon! This polished, prescription-only antineoplastic agent is expertly formulated to ace the fight against ovarian, breast, and non-small cell lung cancers. Supplied as a single 5 ml glass vial (30 mg/vial), it boasts compatibility with 0.9% sodium chloride or 5% dextrose for seamless intravenous use. Complying with Indian drug regulations and featuring a secure barcode, this sterile, odorless solution ensures premium safety under medical supervision. Extended shelf life (24 months) makes it a smart choice for distributors, exporters, and healthcare providers.
Versatile Application of 30 Mg Paclitaxel Injection IP
30 Mg Paclitaxel Injection IP is primarily used as a potent antineoplastic therapy in the clinical management of ovarian, breast, and non-small cell lung cancers. Its plant-derivative origin allows its integration in oncology protocols where broad-spectrum efficacy is required. Additionally, its compatibility with various intravenous solutions expands its application flexibility in different clinical settings, ensuring optimized administration based on patient needs. Single-use vials maintain integrity and sterility for each application.
Shipping, Certification, and Supply of 30 Mg Paclitaxel Injection IP
Shipped goods depart from certified FOB ports across India, supported by robust transport services for timely, secure delivery. Products are backed with required certifications ensuring adherence to Indian regulatory standards. List prices reflect market competitiveness while maintaining first-class quality. Our vast supply ability meets the demands of hospitals, distributors, and traders with responsive logistics-guaranteeing that this acclaimed anti-cancer solution reaches you with reliability and efficiency.
FAQ's of 30 Mg Paclitaxel Injection IP:
Q: How should 30 Mg Paclitaxel Injection IP be administered?
A: This injection is administered intravenously under the direct supervision of medical professionals, using either 0.9% sodium chloride or 5% dextrose as compatible infusion solutions.
Q: What conditions is the 30 Mg Paclitaxel Injection IP indicated for?
A: It is an antineoplastic agent indicated for the treatment of ovarian cancer, breast cancer, and non-small cell lung cancer.
Q: When should extra precautions be taken during use?
A: Extra precautions are essential during administration due to possible hypersensitivity reactions. Medical supervision is required at all times during infusion.
Q: Where can I verify the product's authenticity and regulatory compliance?
A: A barcode is available on the packaging, and the product fully complies with Indian Drug Regulations, ensuring authenticity and approved standards.
Q: What are the storage instructions for 30 Mg Paclitaxel Injection IP?
A: Store the injection below 25C, protect it from light, and do not freeze to maintain product integrity throughout its 24-month shelf life.
Q: How can distributors or suppliers benefit from this product?
A: Distributors benefit from its broad-spectrum efficacy, extended shelf life, secure packaging, and regulatory compliance, making it a reliable choice for supply chains.